| UniProt/SwissProt ID: | EP300_HUMAN |
| Description: | E1A binding protein p300 [Source:HGNC Symbol;Acc:3373] |
| Location: | chr22 q13.2 |
| Node attribute: | acetylation(source); substrate; TF |
| Phosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| S89 | LLRSGsSPNLN | PKC_alpha | phosphoELM |
| S89 | LLRSGsSPNLN | PKC_delta | phosphoELM |
| S1834 | RRRMAsMQRTG | PKB_group | phosphoELM |
| S89 | LLRSGsSPNLN | CaM-KI_group | phosphoELM |
| S1037 | TSATQsSPAPG | PhosphoSitePlus; HPRD; phosphoELM | |
| S24 | SSPALsASASD | CaMK4 | RegPhos |
| S833 | HQNSPsPVPSR | PhosphoSitePlus | |
| T938 | PPQPAtPLSQP | PhosphoSitePlus | |
| S2328 | PHSSPsPRMQP | PhosphoSitePlus | |
| S1044 | PAPGQsKKKIF | PhosphoSitePlus | |
| Y1414 | LRTAVyHEILI | KAT11 | PhosphoSitePlus |
| S2309 | SNQVRsPQPVP | PhosphoSitePlus | |
| S1834 | RRRMAsMQRTG | PhosphoSitePlus | |
| S1834 | RRRMAsMQRTG | AKT1 | HPRD; RegPhos |
| Y1446 | SEGDDyIFHCH | KAT11 | PhosphoSitePlus |
| Y620 | VEGDMyESANN | KIX | PhosphoSitePlus |
| S2366 | QGHFAsPDQNS | PhosphoSitePlus | |
| Y1424 | IGYLEyVKKLG | KAT11 | PhosphoSitePlus |
| T841 | PSRTPtPHHTP | PhosphoSitePlus | |
| S2279 | QPNPMsPQQHM | PhosphoSitePlus | |
| S1038 | SATQSsPAPGQ | PhosphoSitePlus; HPRD | |
| T845 | PTPHHtPPSIG | PhosphoSitePlus | |
| Y638 | LAEKIyKIQKE | KIX | PhosphoSitePlus |
| S1834 | RRRMAsMQRTG | AKT_group | RegPhos |
| T839 | PVPSRtPTPHH | PhosphoSitePlus | |
| T885 | PPPRQtPTPPT | PhosphoSitePlus; HPRD; phosphoELM | |
| S89 | LLRSGsSPNLN | CaMK1_group | RegPhos |
| S12 | EPGPPsAKRPK | PhosphoSitePlus | |
| T1296 | KRLPStRLGTF | PhosphoSitePlus | |
| S89 | LLRSGsSPNLN | PKCa(PKC alpha | RegPhos |
| S831 | ALHQNsPSPVP | PhosphoSitePlus | |
| S89 | LLRSGsSPNLN | AMPK_group | phosphoELM; RegPhos |
| S1295 | AKRLPsTRLGT | PhosphoSitePlus | |
| S1534 | REENTsNESTD | KAT11 | PhosphoSitePlus |
| T1960 | QMPPMtPMAPM | PhosphoSitePlus | |
| T1533 | KREENtSNEST | KAT11 | PhosphoSitePlus |
| S89 | LLRSGsSPNLN | PKCd | RegPhos |
| S285 | LSNNLsPFAMD | PhosphoSitePlus; HPRD | |
| S2315 | PQPVPsPRPQS | PhosphoSitePlus | |
| S24 | SSPALsASASD | CaM-KIV | phosphoELM |
| T1857 | PATPTtPTGQQ | HPRD | |
| Y630 | NRAEYyHLLAE | KIX | PhosphoSitePlus |
| Y611 | ENLVAyARKVE | KIX | PhosphoSitePlus |
| Y1421 | EILIGyLEYVK | KAT11 | PhosphoSitePlus |
| S89 | LLRSGsSPNLN | PKCd(PKC delta | RegPhos |
| Y1355 | AESFPyRTKAL | KAT11 | PhosphoSitePlus |
| T887 | PRQTPtPPTTQ | PhosphoSitePlus; HPRD | |
| Y2219 | PQGVGyPPQQQ | PhosphoSitePlus | |
| Y629 | NNRAEyYHLLA | KIX | PhosphoSitePlus |
| T1135 | LYNRKtSRVYK | Bromodomain | PhosphoSitePlus |
| T317 | QPGLVtPVAQG | PhosphoSitePlus | |
| S89 | LLRSGsSPNLN | PhosphoSitePlus; phosphoELM | |
| S106 | GQVMAsQAQQS | PhosphoSitePlus | |
| S89 | LLRSGsSPNLN | PRKCD | HPRD |
| T1859 | TPTTPtGQQPT | HPRD | |
| Dephosphorylation site |
| EP300_HUMAN do not have dephosphorylation site. |
| Mutation site |
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|---|---|---|---|
| ENSP00000263253 | Y1397H | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | P1452H | COSMIC | Skin Cancer | 21984974 |
| ENSP00000263253 | Y1131N | BIOMART | Hepatocellular Carcinoma | 21930507, 21930502 |
| ENSP00000263253 | R580* | COSMIC | Intestines Cancer | 10700188 |
| ENSP00000263253 | E1013G | HPI, COSMIC | Breast Cancer | 10700188 |
| ENSP00000263253 | P1880S | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000263253 | E1014* | COSMIC | Intestines Cancer | 12402157 |
| ENSP00000263253 | R1680C | COSMIC | Intestines Cancer | 8622873 |
| ENSP00000263253 | P2221Q | COSMIC | Intestines Cancer | 10700188 |
| ENSP00000263253 | R86* | COSMIC | Intestines Cancer | 12385008 |
| ENSP00000263253 | F2211L | BIOMART | Brain Cancer | 21930507, 21930502 |
| ENSP00000263253 | D1399Y | COSMIC | Gastric Cancer | 8622873 |
| ENSP00000263253 | S1650Y | HPI, COSMIC | Pancreatic Cancer | 10700188 |
| ENSP00000263253 | Q974* | COSMIC | Skin Cancer | 22006338 |
| ENSP00000263253 | D618E | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000263253 | S697N | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000263253 | S507G | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | P2221Q | OMIM, HPI | Colorectal Cancer | 10700188 |
| ENSP00000263253 | K1570N | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | A2143T | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000263253 | R1599H | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | R1312* | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000263253 | G1506V | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | R1950S | COSMIC | Lung Cancer | |
| ENSP00000263253 | M2175L | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | L2303F | COSMIC | Skin Cancer | 21984974 |
| ENSP00000263253 | R1627W | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | C1790G | BIOMART | chronic lymphocytic leukemia | 21930507, 21930502 |
| ENSP00000263253 | L827P | HPI, COSMIC | Breast Cancer | 10700188 |
| ENSP00000263253 | A590P | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | P1337S | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000263253 | P925T | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | E646Q | COSMIC | Breast Cancer | 20668451 |
| ENSP00000263253 | Q1904P | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | Q821* | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | M126V | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | Q63* | COSMIC | Lymphoma | 21390126 |
| ENSP00000263253 | C1385F | COSMIC | Head and Neck Cancer | 21798893 |
| Differential expressed protein |
| EP300_HUMAN is not differential expressed protein. |
| Hyperphosphorylation site |
| EP300_HUMAN do not have hyperphosphorylation site. |
| Direct Interaction Pair |
| Source | Target | Relationship | Resource |
|---|---|---|---|
| AAPK2_HUMAN | EP300_HUMAN | kinase -> substrate | RegPhos |
| KPCA_HUMAN | EP300_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| KPCD_HUMAN | EP300_HUMAN | kinase -> substrate | HPRD; Robert H Newman (2013) |
| AKT1_HUMAN | EP300_HUMAN | kinase -> substrate | HPRD; RegPhos |
| EP300_HUMAN | STAT3_HUMAN | acetylation | NetPath |
| EP300_HUMAN | ANDR_HUMAN | acetylation | NetPath |
| EP300_HUMAN | CCND1_HUMAN | TF -> target gene | TRANSFAC |
| Function Annotation |
| KEGG Pathway |
| KEGG ID | Pathway |
|---|---|
| hsa04720 | Long-term potentiation |
| hsa05211 | Renal cell carcinoma |
| hsa04630 | Jak-STAT signaling pathway |
| hsa04330 | Notch signaling pathway |
| hsa05200 | Pathways in cancer |
| hsa05166 | HTLV-I infection |
| hsa04916 | Melanogenesis |
| hsa05203 | Viral carcinogenesis |
| hsa04520 | Adherens junction |
| hsa04110 | Cell cycle |
| hsa05215 | Prostate cancer |
| hsa05016 | Huntington's disease |
| hsa04350 | TGF-beta signaling pathway |
| hsa04310 | Wnt signaling pathway |
| hsa05164 | Influenza A |
| hsa05169 | Epstein-Barr virus infection |
| hsa05152 | Tuberculosis |
| hsa05168 | Herpes simplex infection |
| Gene Ontology |
| GO ID | GO_Term | Evidence | Ontology |
|---|---|---|---|
| GO:0042771 | intrinsic apoptotic signaling pathway in response | IDA | biological_process |
| GO:0045944 | positive regulation of transcription from RNA poly | IEA | biological_process |
| GO:0051091 | positive regulation of sequence-specific DNA bindi | IDA | biological_process |
| GO:0001756 | somitogenesis | IEA | biological_process |
| GO:0043923 | positive regulation by host of viral transcription | IDA | biological_process |
| GO:0001666 | response to hypoxia | IDA | biological_process |
| GO:0004468 | lysine N-acetyltransferase activity | IDA | molecular_function |
| GO:0071456 | cellular response to hypoxia | TAS | biological_process |
| GO:0043967 | histone H4 acetylation | IMP | biological_process |
| GO:0003677 | DNA binding | IEA | molecular_function |
| GO:0000122 | negative regulation of transcription from RNA poly | IDA | biological_process |
| GO:0006351 | transcription, DNA-dependent | IEA | biological_process |
| GO:0032092 | positive regulation of protein binding | IEA | biological_process |
| GO:0001102 | RNA polymerase II activating transcription factor | IEA | molecular_function |
| GO:0016407 | acetyltransferase activity | IMP | molecular_function |
| GO:0009887 | organ morphogenesis | IEA | biological_process |
| GO:0005515 | protein binding | IEA | molecular_function |
| GO:0007049 | cell cycle | IEA | biological_process |
| GO:0001102 | RNA polymerase II activating transcription factor | IPI | molecular_function |
| GO:0007219 | Notch signaling pathway | TAS | biological_process |
| GO:0003712 | transcription cofactor activity | IEA | molecular_function |
| GO:0060765 | regulation of androgen receptor signaling pathway | IDA | biological_process |
| GO:0033613 | activating transcription factor binding | IPI | molecular_function |
| GO:0006355 | regulation of transcription, DNA-dependent | IEA | biological_process |
| GO:0008270 | zinc ion binding | IEA | molecular_function |
| GO:0005634 | nucleus | IDA | cellular_component |
| GO:0043627 | response to estrogen stimulus | IDA | biological_process |
| GO:0045087 | innate immune response | TAS | biological_process |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0001047 | core promoter binding | IDA | molecular_function |
| GO:0003682 | chromatin binding | IMP | molecular_function |
| GO:0050681 | androgen receptor binding | IPI | molecular_function |
| GO:0045893 | positive regulation of transcription, DNA-dependen | IEA | biological_process |
| GO:0018076 | N-terminal peptidyl-lysine acetylation | IDA | biological_process |
| GO:0004402 | histone acetyltransferase activity | IDA | molecular_function |
| GO:0008134 | transcription factor binding | IPI | molecular_function |
| GO:0005737 | cytoplasm | IDA | cellular_component |
| GO:0005667 | transcription factor complex | IEA | cellular_component |
| GO:0033554 | cellular response to stress | TAS | biological_process |
| GO:0007519 | skeletal muscle tissue development | IEA | biological_process |
| GO:0061418 | regulation of transcription from RNA polymerase II | TAS | biological_process |
| GO:0006355 | regulation of transcription, DNA-dependent | IDA | biological_process |
| GO:0007507 | heart development | IEA | biological_process |
| GO:0005654 | nucleoplasm | TAS | cellular_component |
| GO:0018393 | internal peptidyl-lysine acetylation | IDA | biological_process |
| GO:0031490 | chromatin DNA binding | IEA | molecular_function |
| GO:0002039 | p53 binding | IEA | molecular_function |
| GO:0016746 | transferase activity, transferring acyl groups | IDA | molecular_function |
| GO:0003677 | DNA binding | IDA | molecular_function |
| GO:0000123 | histone acetyltransferase complex | IEA | cellular_component |
| GO:0030324 | lung development | IEA | biological_process |
| GO:0006915 | apoptotic process | IMP | biological_process |
| GO:0045944 | positive regulation of transcription from RNA poly | IDA | biological_process |
| GO:0007399 | nervous system development | TAS | biological_process |
| GO:0016573 | histone acetylation | IEA | biological_process |
| GO:0019048 | virus-host interaction | IEA | biological_process |
| GO:0008013 | beta-catenin binding | IPI | molecular_function |
| GO:0003713 | transcription coactivator activity | IDA | molecular_function |
| GO:0001085 | RNA polymerase II transcription factor binding | IEA | molecular_function |